| 发明名称 |
IMPROVED CANCER THERAPY BASED ON TUMOR ASSOCIATED ANTIGENS DERIVED FROM CYCLIN D1. |
| 摘要 |
<p>The present invention relates to cyclin D1-derived peptides for use in the improved treatment of cancer in a patient, particularly in the form of a combination therapy using a vaccine. Other aspects relate to the use of the peptides or a combination thereof as a diagnostic tool.</p> |
| 申请公布号 |
MX2012013998(A) |
申请公布日期 |
2013.01.28 |
| 申请号 |
MX20120013998 |
申请日期 |
2011.06.01 |
| 申请人 |
IMMATICS BIOTECHNOLOGIES GMBH.* |
发明人 |
HARPREET SINGH;STEFFEN WALTER;TONI WEINSCHENK |
| 分类号 |
A61K38/04;A61K39/00;A61K45/06;A61P35/00;C07K14/47 |
主分类号 |
A61K38/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
